The UGT2B7 gene helps your liver add a small chemical tag to certain medicines, hormones, and natural waste products so your body can clear them. If it works less well, some drugs may stay in the body longer or be processed differently, which can change side effects or how well a treatment works. Many variants are harmless, while a few may change how the gene handles medicines such as morphine. UGT2B7 is mainly known in medicine and drug research rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, which are the working parts of cells. Others mainly control when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can read more in the LearnHub.
Overview
UGT2B7Gene function
What if the gene works
The UGT2B7 gene helps your body break down and clear many medicines, hormones, and natural waste products. Its protein makes these substances more water soluble, so the liver and kidneys can remove them more easily.
Risk
What if the gene does not work
Variants in the UGT2B7 gene can range from mild to more severe and may partly or greatly reduce a cell’s ability to add glucuronic acid, a chemical tag, to medicines and natural compounds. This can change their processing for removal.
Treatment
What does that mean for your treatment
No UGT2B7 specific treatment or management approach is currently established for people with a pathogenic or loss of function variant in the UGT2B7 gene. The UGT2B7 gene is being studied as a pharmacogenetic biomarker because it helps process medicines such as morphine and some anti seizure drugs, but these findings do not yet guide routine drug choices in clinical guidelines.
Gene function
What if the gene works
Your liver and some other tissues use the UGT2B7 gene to package certain chemicals for safe removal. It gives instructions for an enzyme that adds glucuronic acid, a small tag that helps substances mix with water. This is a key step in how the UGT2B7 gene affects drug processing and the handling of some natural body chemicals.
The UGT2B7 gene helps cells attach glucuronic acid, a small tag, to selected substances. This often makes them easier to dissolve in water and move out of the body.
Its enzyme works mainly in the liver to process many medicines after your body has started breaking them down. This step helps prepare them for removal in urine or bile.
UGT2B7 also helps process some hormones and other compounds your body makes during normal daily metabolism. By packaging these molecules for clearance, it supports a steady chemical balance.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the UGT2B7 gene can change the shape, stability, or amount of the UGT2B7 enzyme, which may slow how cells attach glucuronic acid, a small chemical tag, to certain medicines and natural body compounds. This helps explain how UGT2B7 gene variants affect enzyme activity: some are milder and only slightly reduce function, while more disruptive variants can markedly lower activity or leave little working enzyme. The exact effect often depends on the specific variant and the substance being processed.
How variants are linked to conditions
Current evidence does not yet show a broadly confirmed link between variants in the UGT2B7 gene and a specific inherited health condition. Research on UGT2B7 gene variants and health conditions is ongoing, and some reported associations have not reached broad clinical agreement. If you have a confirmed UGT2B7-related result, your doctor or genetic counselor can explain what it means in the context of your own health.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the UGT2B7 gene itself. UGT2B7 is better known for changing how some people process certain medicines, so personal risk often depends more on the drug, the dose, liver health, age, and other genes.
Inheritance of UGT2B7 variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific UGT2B7-related condition, so the answer to how UGT2B7 gene variants are inherited is still limited to general genetics rather than one named dominant or recessive pattern. The UGT2B7 gene is on chromosome 4, which is an autosome, so you inherit one copy from your mother and one copy from your father. Any UGT2B7 variant can therefore be passed down through either side of the family.
What does my UGT2B7 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific, well-recognized health condition for UGT2B7. If you have a UGT2B7 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help put it in the context of your family history and the exact result.
Genetic information
Genetic testing
How you find out about variants
Variants in the UGT2B7 gene are found through a lab test that reads your DNA, usually from a blood sample, cheek swab, or saliva sample. UGT2B7 genetic testing for drug response looks for specific DNA changes and compares them with known variants that may affect how your body handles certain medicines.
When should I consider getting a genetic test?
There isn't yet a broadly established, UGT2B7-specific clinical reason for testing. In some cases, it may be included in broader testing about how the body handles certain medicines, but the decision is usually based on your health history, family history, and current treatment plan with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they reveal depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help place individual experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Small differences in the genes involved in handling medicines can change how the body breaks down, moves, or responds to a drug. These differences are common and can influence both how well a medication works and how sensitive you may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences shape a person’s response to medications. It focuses on relationships between genes and drugs to help explain why the same treatment can work differently in different people. With many medicines, genes can influence either how powerful a drug’s effects are or how the body breaks it down and handles it. This understanding can support treatment decisions that are both more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the UGT2B7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, pain control, or other treatment concerns are best discussed with your doctor. Researchers have studied the UGT2B7 gene because it helps the body process some medicines, including morphine and some anti-seizure and antiviral treatments, but these findings are not widely used on their own to direct care.
History
UGT2B7 entered medical research as scientists worked to sort the UGT family, a group of genes involved in how the body handles many medicines and natural substances. In the 1990s, researchers began exploring how this gene works as laboratory studies linked it to the processing of morphine, zidovudine, and other widely used drugs. Building on this early work, scientists mapped the UGT2B7 gene to chromosome 4 and showed that it belonged to a cluster of closely related UGT genes. Its history is tied closely to the growth of pharmacogenetics, the study of how genes can shape drug response. Over time, descriptions became more precise as researchers compared common variants and studied why people can process the same medicine differently.